MicroRNA-301a Mediated Regulation of Kv4.2 in Diabetes: Identification of Key Modulators

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Panguluri, Siva K ^a   Tur, Jared ^a,b   Chapalamadugu, Kalyan C ^a   Katnik, Chris ^b   Cuevas, Javier ^b   Tipparaju, Srinivas M ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRX5 PROTEIN; MICRORNA; MICRORNA 301A; POTASSIUM CHANNEL INTERACTING PROTEIN 2; POTASSIUM CHANNEL KV4.2; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HEART; HEART VENTRICLE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; VALIDATION STUDY;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHIES; HEART VENTRICLES; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICRORNAS; MOLECULAR SEQUENCE DATA; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; RATS; RNA INTERFERENCE; SHAL POTASSIUM CHANNELS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 84875715362     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060545     Document Type: Article

References (59)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M, (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234.
2. Yeung CY, Lam KS, Li SW, Lam KF, Tse HF, et al. (2012) Sudden Cardiac Death After Myocardial Infarction in Type 2 Diabetic Patients With No Residual Myocardial Ischemia. Diabetes Care.
3. Casis O, Gallego M, Iriarte M, Sanchez-Chapula JA, (2000) Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle. Diabetologia 43: 101-109.
4. Li X, Xu Z, Li S, Rozanski GJ, (2005) Redox regulation of Ito remodeling in diabetic rat heart. Am J Physiol Heart Circ Physiol 288: H1417-1424.
5. Nishiyama A, Ishii DN, Backx PH, Pulford BE, Birks BR, et al. (2001) Altered K(+) channel gene expression in diabetic rat ventricle: isoform switching between Kv4.2 and Kv1.4. American journal of physiology Heart and circulatory physiology 281: H1800-1807.
6. Heather LC, Clarke K, (2011) Metabolism, hypoxia and the diabetic heart. Journal of molecular and cellular cardiology 50: 598-605.
7. Fein FS, (1990) Diabetic cardiomyopathy. Diabetes care 13: 1169-1179.
8. Fein FS, Aronson RS, Nordin C, Miller-Green B, Sonnenblick EH, (1983) Altered myocardial response to ouabain in diabetic rats: mechanics and electrophysiology. Journal of molecular and cellular cardiology 15: 769-784.
9. Malhotra A, Penpargkul S, Fein FS, Sonnenblick EH, Scheuer J, (1981) The effect of streptozotocin-induced diabetes in rats on cardiac contractile proteins. Circulation research 49: 1243-1250.
10. Khavandi K, Khavandi A, Asghar O, Greenstein A, Withers S, et al. (2009) Diabetic cardiomyopathy--a distinct disease? Best practice & research Clinical endocrinology & metabolism 23: 347-360.
11. Hu S, Huang M, Li Z, Jia F, Ghosh Z, et al. (2010) MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122: S124-131.
12. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, et al. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proceedings of the National Academy of Sciences of the United States of America 105: 13027-13032.
13. Yang B, Lin H, Xiao J, Lu Y, Luo X, et al. (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nature medicine 13: 486-491.
14. Veglio M, Chinaglia A, Cavallo-Perin P, (2004) QT interval, cardiovascular risk factors and risk of death in diabetes. Journal of endocrinological investigation 27: 175-181.
15. Qin D, Huang B, Deng L, El-Adawi H, Ganguly K, et al. (2001) Downregulation of K(+) channel genes expression in type I diabetic cardiomyopathy. Biochemical and biophysical research communications 283: 549-553.
16. Guo W, Jung WE, Marionneau C, Aimond F, Xu H, et al. (2005) Targeted deletion of Kv4.2 eliminates I(to,f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circulation research 97: 1342-1350.
17. Barry DM, Xu H, Schuessler RB, Nerbonne JM, (1998) Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 alpha subunit. Circulation research 83: 560-567.
18. Lugo JN, Brewster AL, Spencer CM, Anderson AE, (2012) Kv4.2 knockout mice have hippocampal-dependent learning and memory deficits. Learning & memory 19: 182-189.
19. Yuan W, Burkhalter A, Nerbonne JM, (2005) Functional role of the fast transient outward K+ current IA in pyramidal neurons in (rat) primary visual cortex. The Journal of neuroscience: the official journal of the Society for Neuroscience 25: 9185-9194.
20. van Rooij E, Marshall WS, Olson EN, (2008) Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circulation research 103: 919-928.
21. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, et al. (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129: 303-317.
22. Lu Z, Li Y, Takwi A, Li B, Zhang J, et al. (2011) miR-301a as an NF-kappaB activator in pancreatic cancer cells. The EMBO journal 30: 57-67.
23. Panama BK, Latour-Villamil D, Farman GP, Zhao D, Bolz SS, et al. (2011) Nuclear factor kappaB downregulates the transient outward potassium current I(to,f) through control of KChIP2 expression. Circulation research 108: 537-543.
24. Feng B, Chen S, George B, Feng Q, Chakrabarti S, (2010) miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes/metabolism research and reviews 26: 40-49.
25. Panguluri SK, Kakar SS, (2009) Effect of PTTG on endogenous gene expression in HEK 293 cells. BMC genomics 10: 577.
26. Tipparaju SM, Li XP, Kilfoil PJ, Xue B, Uversky VN, et al. (2012) Interactions between the C-terminus of Kv1.5 and Kvbeta regulate pyridine nucleotide-dependent changes in channel gating. Pflugers Archiv: European journal of physiology 463: 799-818.
27. Panguluri SK, Bhatnagar S, Kumar A, McCarthy JJ, Srivastava AK, et al. (2010) Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice. PloS one 5: e8760.
28. Zhang H, Cuevas J, (2005) sigma Receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons. The Journal of pharmacology and experimental therapeutics 313: 1387-1396.
29. Semeniuk LM, Kryski AJ, Severson DL, (2002) Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. American journal of physiology Heart and circulatory physiology 283: H976-982.
30. Bhatnagar S, Panguluri SK, Gupta SK, Dahiya S, Lundy RF, et al. (2010) Tumor necrosis factor-alpha regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PloS one 5: e13262.
31. Fernandez-Velasco M, Ruiz-Hurtado G, Hurtado O, Moro MA, Delgado C, (2007) TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. American journal of physiology Heart and circulatory physiology 293: H238-245.
32. Petkova-Kirova PS, Gursoy E, Mehdi H, McTiernan CF, London B, et al. (2006) Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. American journal of physiology Heart and circulatory physiology 290: H2098-2107.
33. Kawada H, Niwano S, Niwano H, Yumoto Y, Wakisaka Y, et al. (2006) Tumor necrosis factor-alpha downregulates the voltage gated outward K+ current in cultured neonatal rat cardiomyocytes: a possible cause of electrical remodeling in diseased hearts. Circulation journal: official journal of the Japanese Circulation Society 70: 605-609.
34. Shimoni Y, Liu XF, (2003) Role of PKC in autocrine regulation of rat ventricular K+ currents by angiotensin and endothelin. American journal of physiology Heart and circulatory physiology 284: H1168-1181.
35. Kuo HC, Cheng CF, Clark RB, Lin JJ, Lin JL, et al. (2001) A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 107: 801-813.
36. Costantini DL, Arruda EP, Agarwal P, Kim KH, Zhu Y, et al. (2005) The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell 123: 347-358.
37. He W, Jia Y, Takimoto K, (2009) Interaction between transcription factors Iroquois proteins 4 and 5 controls cardiac potassium channel Kv4.2 gene transcription. Cardiovascular research 81: 64-71.
38. Shimoni Y, Chuang M, Abel ED, Severson DL, (2004) Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice. The Journal of physiology 555: 345-354.
39. Radicke S, Cotella D, Graf EM, Banse U, Jost N, et al. (2006) Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts. Cardiovascular research 71: 695-703.
40. Gidh-Jain M, Huang B, Jain P, el-Sherif N, (1996) Differential expression of voltage-gated K+ channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circulation research 79: 669-675.
41. Kaprielian R, Wickenden AD, Kassiri Z, Parker TG, Liu PP, et al. (1999) Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction. The Journal of physiology 517 (Pt1): 229-245.
42. An WF, Bowlby MR, Betty M, Cao J, Ling HP, et al. (2000) Modulation of A-type potassium channels by a family of calcium sensors. Nature 403: 553-556.
43. Wang Y, Xu H, Kumar R, Tipparaju SM, Wagner MB, et al. (2003) Differences in transient outward current properties between neonatal and adult human atrial myocytes. Journal of molecular and cellular cardiology 35: 1083-1092.
44. Mariappan N, Elks CM, Sriramula S, Guggilam A, Liu Z, et al. (2010) NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovascular research 85: 473-483.
45. Yue P, Arai T, Terashima M, Sheikh AY, Cao F, et al. (2007) Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. American Journal of Physiology- Heart and Circulatory Physiology 292: H2106-H2118.
46. Milstein ML, Musa H, Balbuena DP, Anumonwo JMB, Auerbach DS, et al. (2012) Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmia. Proceedings of the National Academy of Sciences.
47. Rosati B, Grau F, McKinnon D, (2006) Regional variation in rnRNA transcript abundance within the ventricular wall. Journal of molecular and cellular cardiology 40: 295-302.
48. Costantini DL, Arruda EP, Agarwal P, Kim KH, Zhu YH, et al. (2005) The homeodomain transcription factor lrx5 establishes the mouse cardiac ventricular repolarization gradient. Cell 123: 347-358.
49. Laverriere AC, MacNeill C, Mueller C, Poelmann RE, Burch JB, et al. (1994) GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. The Journal of biological chemistry 269: 23177-23184.
50. Jia Y, Takimoto K, (2003) GATA and FOG2 transcription factors differentially regulate the promoter for Kv4.2 K+ channel gene in cardiac myocytes and PC12 cells. Cardiovascular research 60: 278-287.
51. Wong SC, Fukuchi M, Melnyk P, Rodger I, Giaid A, (1998) Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation 98: 100-103.
52. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, et al. (2001) Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proceedings of the National Academy of Sciences of the United States of America 98: 6668-6673.
53. Higuchi Y, Otsu K, Nishida K, Hirotani S, Nakayama H, et al. (2002) Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. Journal of molecular and cellular cardiology 34: 233-240.
54. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, et al. (2008) Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. Journal of molecular biology 375: 637-649.
55. Gupta S, Young D, Sen S, (2005) Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats. American journal of physiology Heart and circulatory physiology 289: H20-29.
56. Kumar A, Lin Z, SenBanerjee S, Jain MK, (2005) Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases. Molecular and cellular biology 25: 5893-5899.
57. Naga Prasad SV, Duan ZH, Gupta MK, Surampudi VS, Volinia S, et al. (2009) Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. The Journal of biological chemistry 284: 27487-27499.
58. Nitabach MN, Llamas DA, Araneda RC, Intile JL, Thompson IJ, et al. (2001) A mechanism for combinatorial regulation of electrical activity: Potassium channel subunits capable of functioning as Src homology 3-dependent adaptors. Proceedings of the National Academy of Sciences of the United States of America 98: 705-710.
59. Balza RO Jr, Misra RP, (2006) Role of the serum response factor in regulating contractile apparatus gene expression and sarcomeric integrity in cardiomyocytes. The Journal of biological chemistry 281: 6498-6510.